SUSAN KOLLER: Open Payments
NPI 1841212305 · VALATIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 21 payments from 8 companies in 2025. Trend: 2023 $589 · 2024 $427 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $102 |
| Exeltis, USA Inc. | 3 | $71 |
| Exact Sciences Corporation | 3 | $62 |
| Novo Nordisk Inc | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Astellas Pharma US Inc | 2 | $40 |
| Lilly USA, LLC | 2 | $37 |
| Dexcom, Inc. | 1 | $32 |
Products named: MYFEMBREE, SLYND, The Cologuard Plus Collection Kit, Wegovy, Veozah, ZEPBOUND, Dexcom G6 Transmitter, Mirena.
Industry payments across NY — which companies pay providers there.
